Globus Medical Inc. (NYSE:GMED), a medical device company with a market capitalization of $12 billion and an "GREAT" financial health rating according to InvestingPro, reaffirmed its commitment to ...
Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...
Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
The Globus-M and now -M2 are primarily for scientific research and technology demonstration. They show the potential for spherical tokamaks to generate hybrid fusion-fission nuclear power.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback